VetCell Therapeutics Presenting Canine Allogenic MSC Study Results and Unveiling Cell Therapy Extended Shipping Solution at NAVRMA 2019

by Michael Farino | Sep 5, 2019 | Press Releases

SANTA ANA, Calif., September 5, 2019–VetCell Therapeutics USA, a pet-focused cell therapy division of PrimeGen Global, Inc., announced today that the company will be presenting multiple presentations at the North American Veterinary Regenerative Medicine Association’s...

Cal Poly Pomona Masters Grad Excites Peers With Atopic Dermatitis Thesis Presentation

by Michael Farino | Aug 2, 2019 | Blog

It’s not every day you earn a master’s degree, but we’re particularly thrilled for Ana Ramirez, a newly minted Master of Science graduate of Cal Poly Pomona. Ana, now a vet student at Western U, worked on both the clinical and laboratory side of the Canine Atopic...

VetCell’s Canine Atopic Dermatitis Study Hits Major Milestone!

by Michael Farino | Feb 21, 2019 | Blog

Last February, we proudly announced the partnership of VetCell Therapeutics and College of Veterinary Medicine at Western University of Health Sciences’ for a preclinical study on the effects of using Mesenchymal Stem Cells (MSC) for treating canine Atopic dermatitis...

vetcell-in-the-news redirect

by Michael Farino | Nov 8, 2017 | Uncategorized

veterinarians redirect

by Michael Farino | Nov 8, 2017 | Uncategorized